The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Avolta AG
SWB:D2J
|
CH |
|
A
|
Allstate Corp
SWB:ALS
|
US |
|
S
|
SyntheticMR AB (publ)
OTC:SYNMF
|
SE |
|
J
|
Julius Baer Gruppe AG
DUS:JGE
|
CH |
|
M
|
Mcf Energy Ltd
DUS:DC6
|
CA |
|
B
|
Bouygues SA
DUS:BYG
|
FR |
|
B
|
Barry Callebaut AG
XMUN:BCLN
|
CH |
|
F.C.C. Co Ltd
OTC:FCVFF
|
JP |
|
B
|
Borgwarner Inc
XMUN:BGW
|
US |
Avolta AG (D2J)’s 12-month stock price forecast through January 2025 has a consensus target of €67.5565, implying 11% upside. The forecast is based on price targets from 17 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
D2J is 67.5565 EUR with a low forecast of 57.8892 EUR and a high forecast of 80.2425 EUR.
Over the last 13 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 8 years is 3%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next 8 years is 3%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 8 years is 3%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 7%. The projected CAGR for the next 3 years is 22%.
Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 5 years is 34%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more